These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3524684)

  • 21. The control of the immune response.
    Asherson GL
    Ann Allergy; 1984 Dec; 53(6 Pt 2):557-62. PubMed ID: 6209999
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of biological response modifiers in parasitic infections.
    Ruitenberg EJ; Buys J; Blomjous FJ; de Jong H; Bernadina W
    Dev Biol Stand; 1985; 62():129-38. PubMed ID: 3938740
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunohistochemical analysis of murine mononuclear phagocytes that express class II major histocompatibility antigens.
    Hume DA
    Immunobiology; 1985 Dec; 170(5):381-9. PubMed ID: 3867611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons.
    Warren MK; Vogel SN
    J Immunol; 1985 Feb; 134(2):982-9. PubMed ID: 2578168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The generation of tumoricidal activity in macrophages for the treatment of established metastases.
    Fidler IJ
    Symp Fundam Cancer Res; 1983; 36():421-35. PubMed ID: 6382518
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro assessment of cancer cell-induced polarization of macrophages.
    Duits DEM; Wellenstein MD; de Visser KE
    Methods Enzymol; 2020; 632():133-154. PubMed ID: 32000893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for mononuclear phagocytes in solid neoplasms and appraisal of their nonspecific cytotoxic capabilities.
    Russell SW; Gillespie GY; Pace JL
    Contemp Top Immunobiol; 1980; 10():143-66. PubMed ID: 7408488
    [No Abstract]   [Full Text] [Related]  

  • 28. Macrophages and antitumor reactions.
    Den Otter W; Dullens HF; De Weger RA
    Cancer Immunol Immunother; 1983; 16(2):67-71. PubMed ID: 6362848
    [No Abstract]   [Full Text] [Related]  

  • 29. Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth.
    Garner RE; Malick AP; Elgert KD
    J Leukoc Biol; 1986 Nov; 40(5):561-74. PubMed ID: 3464674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane changes in murine macrophages after in-vivo stimulation and activation.
    Glass EJ; Stewart J; Weir DM
    Immunology; 1983 Sep; 50(1):165-73. PubMed ID: 6350168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of murine mononuclear phagocytes for destroying tumor cells: analysis of effector mechanisms and development.
    Adams DO; Johnson WJ
    Adv Exp Med Biol; 1982; 155():707-20. PubMed ID: 7158506
    [No Abstract]   [Full Text] [Related]  

  • 32. Level of activation determines whether inflammatory peritoneal and intratumoral macrophages will promote or suppress in vitro development of cytolytic T lymphocyte activity.
    Gillespie GY; Russell SW
    J Reticuloendothel Soc; 1980 May; 27(5):535-45. PubMed ID: 7373614
    [No Abstract]   [Full Text] [Related]  

  • 33. Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development.
    Johnson WJ; Marino PA; Schreiber RD; Adams DO
    J Immunol; 1983 Aug; 131(2):1038-43. PubMed ID: 6306103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the human macrophage. II. The in vitro cytotoxicity of macrophages.
    Chang YC; Yao CS
    Eur J Immunol; 1979 Jul; 9(7):521-5. PubMed ID: 291509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
    McBride WH; Woodruff MF; Forbes GM; Moore K
    Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterogeneity of immunologic function among subfractions of normal rat alveolar macrophages. II. Activation as a determinant of functional activity.
    Shellito J; Kaltreider HB
    Am Rev Respir Dis; 1985 May; 131(5):678-83. PubMed ID: 2988384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotypical changes of neoplastic cells and tumor-associated macrophages in a rat dendritic cell sarcoma-derived transplantable tumor line (KB-D8).
    Kawashima M; Ide M; Nakanishi M; Kuwamura M; Kumagai D; Yamate J
    Virchows Arch; 2003 Feb; 442(2):141-50. PubMed ID: 12596065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Morphofunctional characteristics of the placental macrophages in vitro in pregnancies with various outcomes].
    Pavlov OV; Sel'kov SA; Seliutin AV; Andreeva EE; Shamugia MS; Arzhanova ON
    Biull Eksp Biol Med; 1999 Apr; 127(4):429-32. PubMed ID: 10367129
    [No Abstract]   [Full Text] [Related]  

  • 39. Association between immunoglobulin and macrophages in primary methylcholanthrene-induced sarcomas.
    Wood GW; Tilzer SA; Gollahon KA; Lindsay JM
    Cancer Res; 1979 Nov; 39(11):4588-93. PubMed ID: 498089
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
    Walker TM; Burger CJ; Elgert KD
    Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.